TOMBOLA: ctDNA-guided adjuvant post-cystectomy immunotherapy in MIBC

(1:8)

TOMBOLA: Post-Cystectomy Immunotherapy Assessment With ctDNA

(9:14)

Bladder cancer at ESMO 2024: SunRISe-4, TOMBOLA and NIAGARA

(5:8)

TOMBOLA: advancements in post-operative treatment strategies in bladder cancer

(1:1econd)

Understand ctDNA Testing

(3:25)

Enhancing patient selection in bladder cancer through ctDNA testing

(1:31)

ctDNA in MIBC and Adjuvant Treatments Versus Observation

(8:32)

The emerging role of ctDNA in cancer diagnostics

(45)

How can ctDNA analysis guide treatment in cancer?

(48)

Using circulating tumor DNA (ctDNA) for the early detection of cancer.

(2:19)

Using ctDNA to Guide Adjuvant Therapy in Stage II Colorectal Cancer

(3:48)

The role of ctDNA in lung cancer screening

(3:32)

Circulating Tumor DNA (ctDNA) and liquid biopsy

(3:24)

Fundamentals of ctDNA

(4:26)

Ask a Scientist: Circulating Tumor DNA (ctDNA)

(2:3)

CLIMB360: ctDNA-based molecular screening

(1:33)

Tracking clonal evolution in colorectal cancer using ctDNA

(51)

Validating ctDNA-based approaches in clinical trials

(49)

Applications of ctDNA in oncology

(2:6)

ctDNA and MRD: Who, When, and Then What? | 2022 Evolution Conference

(46:53)